Does PIMECROLIMUS Cause Application site erythema? 41 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 41 reports of Application site erythema have been filed in association with PIMECROLIMUS (Pimecrolimus). This represents 3.1% of all adverse event reports for PIMECROLIMUS.
41
Reports of Application site erythema with PIMECROLIMUS
3.1%
of all PIMECROLIMUS reports
0
Deaths
1
Hospitalizations
How Dangerous Is Application site erythema From PIMECROLIMUS?
Of the 41 reports, 1 (2.4%) required hospitalization.
Is Application site erythema Listed in the Official Label?
Yes, Application site erythema is listed as a known adverse reaction in the official FDA drug label for PIMECROLIMUS.
What Other Side Effects Does PIMECROLIMUS Cause?
Drug ineffective (349)
Treatment failure (139)
Psoriasis (114)
Off label use (113)
Pruritus (94)
Erythema (89)
Product use in unapproved indication (86)
Rash (82)
Application site pain (72)
Therapeutic product effect incomplete (65)
What Other Drugs Cause Application site erythema?
NICOTINE (2,004)
SUMATRIPTAN (1,875)
INGENOL MEBUTATE (1,373)
BUPRENORPHINE (1,273)
ESTRADIOL (1,117)
MINOXIDIL (1,061)
METHYLPHENIDATE (543)
ESTRADIOL\NORETHINDRONE (533)
FENTANYL (501)
OXYTROL FOR WOMEN (422)
Which PIMECROLIMUS Alternatives Have Lower Application site erythema Risk?
PIMECROLIMUS vs PIMOZIDE
PIMECROLIMUS vs PINAVERIUM
PIMECROLIMUS vs PINDOLOL
PIMECROLIMUS vs PIOGLITAZONE
PIMECROLIMUS vs PIPAMPERONE